TY - STD TI - Jack CR, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA Research Framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement. 2018. https://doi.org/10.1016/j.jalz.2018.02.018. ID - ref1 ER - TY - STD TI - Jack CR, Bennett DA, Blennow K, Carrillo MC, Feldman HH, Frisoni GB, et al. A/T/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology. 2016. https://doi.org/10.1212/WNL.0000000000002923. ID - ref2 ER - TY - STD TI - Frisoni GB, Boccardi M, Barkhof F, Blennow K, Cappa S, Chiotis K, et al. Strategic roadmap for an early diagnosis of Alzheimer’s disease based on biomarkers. Lancet Neurol. 2017. https://doi.org/10.1016/S1474-4422(17)30159-X. ID - ref3 ER - TY - STD TI - Blennow K, Dubois B, Fagan AM, Lewczuk P, De Leon MJ, Hampel H. Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer’s disease. Alzheimers Dement. 2015. https://doi.org/10.1016/j.jalz.2014.02.004. ID - ref4 ER - TY - STD TI - Grossman I, Lutz MW, Crenshaw DG, Saunders AM, Burns DK, Roses AD. Alzheimer’s disease: diagnostics, prognostics and the road to prevention. EPMA J. 2010. https://doi.org/10.1007/s13167-010-0024-3. ID - ref5 ER - TY - STD TI - Cummings J, Aisen PS, Dubois B, Frölich L, Jack CR, Jones RW, et al. Drug development in Alzheimer’s disease: the path to 2025. Alzheimers Res Ther. 2016. https://doi.org/10.1186/s13195-016-0207-9. ID - ref6 ER - TY - STD TI - London A, Benhar I, Schwartz M. The retina as a window to the brain - from eye research to CNS disorders. Nat Rev Neurol. 2013. https://doi.org/10.1038/nrneurol.2012.227. ID - ref7 ER - TY - STD TI - De Groef L, Cordeiro MF. Is the eye an extension of the brain in central nervous system disease? J Ocul Pharmacol Ther. 2018. https://doi.org/10.1089/jop.2016.0180. ID - ref8 ER - TY - STD TI - Alber J, Goldfarb D, Thompson LI, Arthur E, Hernandez K, Cheng D, et al. Developing retinal biomarkers for the earliest stages of Alzheimer’s disease: what we know, what we don’t, and how to move forward. Alzheimers Dement. 2020. https://doi.org/10.1002/alz.12006. ID - ref9 ER - TY - STD TI - Hart NJ, Koronyo Y, Black KL, Koronyo-Hamaoui M. Ocular indicators of Alzheimer’s: exploring disease in the retina. Acta Neuropathol. 2016. https://doi.org/10.1007/s00401-016-1613-6. ID - ref10 ER - TY - STD TI - Kusne Y, Wolf AB, Townley K, Conway M, Peyman GA. Visual system manifestations of Alzheimer’s disease. Acta Ophthalmol. 2017. https://doi.org/10.1111/aos.13319. ID - ref11 ER - TY - STD TI - Lim JKH, Li QX, He Z, Vingrys AJ, Wong VHY, Currier N, et al. The eye as a biomarker for Alzheimer’s disease. Front Neurosci. 2016. https://doi.org/10.3389/fnins.2016.00536. ID - ref12 ER - TY - STD TI - La Morgia C, Ross-Cisneros FN, Koronyo Y, Hannibal J, Gallassi R, Cantalupo G, et al. Melanopsin retinal ganglion cell loss in Alzheimer disease. Ann Neurol. 2016. https://doi.org/10.1002/ana.24548. ID - ref13 ER - TY - STD TI - Koronyo-Hamaoui M, Koronyo Y, Ljubimov AV, Miller CA, Ko MHK, Black KL, et al. Identification of amyloid plaques in retinas from Alzheimer’s patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Neuroimage. 2011. https://doi.org/10.1016/j.neuroimage.2010.06.020. ID - ref14 ER - TY - STD TI - Kirbas S, Turkyilmaz K, Anlar O, Tufekci A, Durmus M. Retinal nerve fiber layer thickness in patients with Alzheimer disease. J Neuro-Ophthalmology. 2013. https://doi.org/10.1097/WNO.0b013e318267fd5f. ID - ref15 ER - TY - STD TI - Lu Y, Li Z, Zhang X, Ming B, Jia J, Wang R, et al. Retinal nerve fiber layer structure abnormalities in early Alzheimer’s disease: evidence in optical coherence tomography. Neurosci Lett. 2010. https://doi.org/10.1016/j.neulet.2010.06.006. ID - ref16 ER - TY - STD TI - Bambo MP, Garcia-Martin E, Pinilla J, Herrero R, Satue M, Otin S, et al. Detection of retinal nerve fiber layer degeneration in patients with Alzheimer’s disease using optical coherence tomography: searching new biomarkers. Acta Ophthalmol. 2014. https://doi.org/10.1111/aos.12374. ID - ref17 ER - TY - STD TI - Garcia-Martin ES, Rojas B, Ramirez AI, De Hoz R, Salazar JJ, Yubero R, et al. Macular thickness as a potential biomarker of mild Alzheimer’s disease. Ophthalmology. 2014. https://doi.org/10.1016/j.ophtha.2013.12.023. ID - ref18 ER - TY - STD TI - den Haan J, Verbraak FD, Visser PJ, Bouwman FH. Retinal thickness in Alzheimer’s disease: a systematic review and meta-analysis. Alzheimer’s Dement Diagnosis, Assess Dis Monit 2017. doi:https://doi.org/10.1016/j.dadm.2016.12.014. ID - ref19 ER - TY - STD TI - Blanks JC, Hinton DR, Sadun AA, Miller CA. Retinal ganglion cell degeneration in Alzheimer’s disease. Brain Res. 1989. https://doi.org/10.1016/0006-8993(89)90653-7. ID - ref20 ER - TY - STD TI - Hinton DR, Sadun AA, Blanks JC, Miller CA. Optic-nerve degeneration in Alzheimer’s disease. N Engl J Med. 1986. https://doi.org/10.1056/NEJM198608213150804. ID - ref21 ER - TY - STD TI - Blanks JC, Schmidt SY, Torigoe Y, Porrello KV, Hinton DR, Blanks RH. Retinal pathology in Alzheimer’s disease. II. Regional neuron loss and glial changes in GCL. Neurobiol Aging. 1996. ID - ref22 ER - TY - STD TI - Blanks JC, Torigoe Y, Hinton DR, Blanks RHI. Retinal pathology in Alzheimer’s disease. I. Ganglion cell loss in foveal/parafoveal retina. Neurobiol Aging 1996. doi:https://doi.org/10.1016/0197-4580(96)00010-3. ID - ref23 ER - TY - STD TI - Curcio CA, Drucker DN. Retinal ganglion cells in Alzheimer’s disease and aging. Ann Neurol. 1993. https://doi.org/10.1002/ana.410330305. ID - ref24 ER - TY - STD TI - Sadun AA, Bassi CJ. Optic nerve damage in Alzheimer’s disease. Ophthalmology. 1990. https://doi.org/10.1016/S0161-6420(90)32621-0. ID - ref25 ER - TY - STD TI - Bambo MP, Garcia-Martin E, Otin S, Pinilla J, Larrosa JM, Polo V, et al. Visual function and retinal nerve fibre layer degeneration in patients with Alzheimer disease: correlations with severity of dementia. Acta Ophthalmol. 2015. https://doi.org/10.1111/aos.12635. ID - ref26 ER - TY - STD TI - Iseri PK, Altinaş Ö, Tokay T, Yüksel N. Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuro-Ophthalmology. 2006. https://doi.org/10.1097/01.wno.0000204645.56873.26. ID - ref27 ER - TY - STD TI - Garcia-Martin E, Bambo MP, Marques ML, Satue M, Otin S, Larrosa JM, et al. Ganglion cell layer measurements correlate with disease severity in patients with Alzheimer’s disease. Acta Ophthalmol. 2016. https://doi.org/10.1111/aos.12977. ID - ref28 ER - TY - STD TI - El-Ashry M, Appaswamy S, Deokule S, Pagliarini S. The effect of phacoemulsification cataract surgery on the measurement of retinal nerve fiber layer thickness using optical coherence tomography. Curr Eye Res. 2006. https://doi.org/10.1080/02713680600646882. ID - ref29 ER - TY - STD TI - Koronyo Y, Salumbides BC, Black KL, Koronyo-Hamaoui M. Alzheimer’s disease in the retina: imaging retinal Aβ plaques for early diagnosis and therapy assessment. Neurodegener Dis. 2012. https://doi.org/10.1159/000335154. ID - ref30 ER - TY - STD TI - Shah TM, Gupta SM, Chatterjee P, Campbell M, Martins RN. Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer’s disease. Mol Psychiatry. 2017. https://doi.org/10.1038/mp.2016.251. ID - ref31 ER - TY - STD TI - Kayabasi U. Retinal examination for the diagnosis of Alzheimer’s disease. Int J Ophthalmic Pathol. 2014. https://doi.org/10.4172/2324-8599.1000145. ID - ref32 ER - TY - STD TI - Lemmens S, Devulder A, Van Keer K, Bierkens J, De Boever P, Stalmans I. Systematic review on fractal dimension of the retinal vasculature in neurodegeneration and stroke: assessment of a potential biomarker. Front Neurosci. 2020. https://doi.org/10.3389/fnins.2020.00016. ID - ref33 ER - TY - STD TI - More SS, Beach JM, Vince R. Early detection of amyloidopathy in Alzheimer’s mice by hyperspectral endoscopy. Investig Ophthalmol Vis Sci. 2016. https://doi.org/10.1167/iovs.15-17406. ID - ref34 ER - TY - STD TI - More SS, Vince R. Hyperspectral imaging signatures detect amyloidopathy in Alzheimers mouse retina well before onset of cognitive decline. ACS Chem Neurosci. 2015. https://doi.org/10.1021/cn500242z. ID - ref35 ER - TY - STD TI - Hadoux X, Hui F, Lim JKH, Masters CL, Pébay A, Chevalier S, et al. Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer’s disease. Nat Commun. 2019. https://doi.org/10.1038/s41467-019-12242-1. ID - ref36 ER - TY - STD TI - Adamczuk K, Schaeverbeke J, Vanderstichele HMJ, Lilja J, Nelissen N, Van Laere K, et al. Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer’s disease. Alzheimers Res Ther. 2015. https://doi.org/10.1186/s13195-015-0159-5. ID - ref37 ER - TY - STD TI - McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011. https://doi.org/10.1016/j.jalz.2011.03.005. ID - ref38 ER - TY - STD TI - Nobili F, Arbizu J, Bouwman F, Drzezga A, Agosta F, Nestor P, et al. European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus. Eur J Neurol. 2018. https://doi.org/10.1111/ene.13728. ID - ref39 ER - TY - STD TI - Lambrechts A, Gonzalez P, Geelen B, Soussan P, Tack K, Jayapala M. A CMOS-compatible, integrated approach to hyper- and multispectral imaging. In: Technical Digest - International Electron Devices Meeting, IEDM. 2015 doi:https://doi.org/10.1109/IEDM.2014.7047025. ID - ref40 ER - TY - STD TI - Geelen B, Tack N, Lambrechts A. A compact snapshot multispectral imager with a monolithically integrated per-pixel filter mosaic. In: Advanced fabrication technologies for micro/nano optics and photonics VII 2014 doi:https://doi.org/10.1117/12.2037607. ID - ref41 ER - TY - STD TI - Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, et al. Scikit-learn: machine learning in Python. J Mach Learn Res. 2011. ID - ref42 ER - TY - STD TI - Varma S, Simon R. Bias in error estimation when using cross-validation for model selection. BMC Bioinformatics. 2006. https://doi.org/10.1186/1471-2105-7-91. ID - ref43 ER - TY - STD TI - Seibold LK, Mandava N, Kahook MY. Comparison of retinal nerve fiber layer thickness in normal eyes using time-domain and spectral-domain optical coherence tomography. Am J Ophthalmol. 2010. https://doi.org/10.1016/j.ajo.2010.06.024. ID - ref44 ER - TY - STD TI - Quigley HA. Glaucoma. In: The Lancet 2011 doi:https://doi.org/10.1016/S0140-6736(10)61423-7. ID - ref45 ER - TY - STD TI - Chan VTT, Sun Z, Tang S, Chen LJ, Wong A, Tham CC, et al. Spectral-domain OCT measurements in Alzheimer’s disease: a systematic review and meta-analysis. Ophthalmology. 2019. https://doi.org/10.1016/j.ophtha.2018.08.009. ID - ref46 ER - TY - STD TI - Shi Z, Wu Y, Wang M, Cao J, Feng W, Cheng Y, et al. Greater attenuation of retinal nerve fiber layer thickness in Alzheimer’s disease patients. J Alzheimers Dis. 2014. https://doi.org/10.3233/JAD-131898. ID - ref47 ER - TY - STD TI - Trebbastoni A, D’Antonio F, Bruscolini A, Marcelli M, Cecere M, Campanelli A, et al. Retinal nerve fibre layer thickness changes in Alzheimer’s disease: results from a 12-month prospective case series. Neurosci Lett. 2016. https://doi.org/10.1016/j.neulet.2016.07.006. ID - ref48 ER - TY - STD TI - Sharafi SM, Sylvestre JP, Chevrefils C, Soucy JP, Beaulieu S, Pascoal TA, et al. Vascular retinal biomarkers improves the detection of the likely cerebral amyloid status from hyperspectral retinal images. Alzheimer’s Dement Transl Res Clin Interv. 2019. https://doi.org/10.1016/j.trci.2019.09.006. ID - ref49 ER - TY - STD TI - Chung HS, Harris A, Halter PJ, Kagemann L, Roff EJ, Garzozi HJ et al. Regional differences in retinal vascular reactivity. Investig Ophthalmol Vis Sci 1999. ID - ref50 ER - TY - STD TI - Koronyo Y, Biggs D, Barron E, Boyer DS, Pearlman JA, Au WJ, et al. Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer’s disease. JCI insight. 2017. https://doi.org/10.1172/jci.insight.93621. ID - ref51 ER - TY - STD TI - Shi H, Koronyo Y, Rentsendorj A, Regis GC, Sheyn J, Fuchs DT, et al. Identification of early pericyte loss and vascular amyloidosis in Alzheimer’s disease retina. Acta Neuropathol. 2020. https://doi.org/10.1007/s00401-020-02134-w. ID - ref52 ER - TY - STD TI - Schön C, Hoffmann NA, Ochs SM, Burgold S, Filser S, Steinbach S, et al. Long-term in vivo imaging of fibrillar tau in the retina of P301S transgenic mice. PLoS One. 2012. https://doi.org/10.1371/journal.pone.0053547. ID - ref53 ER - TY - STD TI - Ho CY, Troncoso JC, Knox D, Stark W, Eberhart CG. Beta-amyloid, phospho-tau and alpha-synuclein deposits similar to those in the brain are not identified in the eyes of Alzheimer’s and Parkinson’s disease patients. Brain Pathol. 2014. https://doi.org/10.1111/bpa.12070. ID - ref54 ER - TY - STD TI - Williams EA, McGuone D, Frosch MP, Hyman BT, Laver N, Stemmer-Rachamimov A. Absence of Alzheimer disease neuropathologic changes in eyes of subjects with Alzheimer disease. J Neuropathol Exp Neurol. 2017. https://doi.org/10.1093/jnen/nlx020. ID - ref55 ER - TY - STD TI - den Haan J, Morrema THJ, Verbraak FD, de Boer JF, Scheltens P, Rozemuller AJ, et al. Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas. Acta Neuropathol Commun. 2018. https://doi.org/10.1186/s40478-018-0650-x. ID - ref56 ER - TY - STD TI - Grewal DS, Polascik BW, Hoffmeyer GC, Fekrat S. Assessment of differences in retinal microvasculature using OCT angiography in Alzheimer’s disease: a twin discordance report. Ophthalmic Surg Lasers Imaging Retin. 2018. https://doi.org/10.3928/23258160-20180601-09. ID - ref57 ER - TY - STD TI - O’Bryhim BE, Apte RS, Kung N, Coble D, Van Stavern GP. Association of preclinical Alzheimer disease with optical coherence tomographic angiography findings. JAMA Ophthalmol. 2018. https://doi.org/10.1001/jamaophthalmol.2018.3556. ID - ref58 ER - TY - STD TI - Yoon SP, Grewal DS, Thompson AC, Polascik BW, Dunn C, Burke JR, et al. Retinal microvascular and neurodegenerative changes in Alzheimer’s disease and mild cognitive impairment compared with control participants. Ophthalmol Retin. 2019. https://doi.org/10.1016/j.oret.2019.02.002. ID - ref59 ER - TY - STD TI - Van De Kreeke JA, Nguyen HT, Konijnenberg E, Tomassen J, Den Braber A, Ten Kate M, et al. Optical coherence tomography angiography in preclinical Alzheimer’s disease. Br J Ophthalmol. 2019. https://doi.org/10.1136/bjophthalmol-2019-314127. ID - ref60 ER - TY - STD TI - Berisha F, Feke GT, Trempe CL, McMeel JW, Schepens CL. Retinal abnormalities in early Alzheimer’s disease. Investig Ophthalmol Vis Sci. 2007. https://doi.org/10.1167/iovs.06-1029. ID - ref61 ER - TY - STD TI - Szegedi S, Dal-Bianco P, Stögmann E, Traub-Weidinger T, Rainer M, Masching A, et al. Anatomical and functional changes in the retina in patients with Alzheimer’s disease and mild cognitive impairment. Acta Ophthalmol. 2020. https://doi.org/10.1111/aos.14419. ID - ref62 ER -